
HealthMore in Health→
GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment
Key Takeaways
- Novo Nordisk's oral Wegovy is now available, with Lilly's orforglipron approval expected soon
- Creating oral GLP-1 drugs required solving major absorption challenges with peptide molecules
- The pill format could dramatically expand the $50 billion+ GLP-1 market to new patient populations
DE
DT Editorial Team··3 min read·via statnews.com